Impel NeuroPharma

/Impel NeuroPharma

IPO

Impel NeuroPharma

Pharmaceutical

We are a late-stage pharmaceutical company focused on utilizing our proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system, or CNS.

Symbol

IMPL

Price Range
$14.00 - $16.00

Final Shares
5,333,334

Anticipated Date
April 23, 2021

Underwriters
COWEN AND COMPANY, LLC

This offering is no longer available

To view the prospectus for Impel NeuroPharma IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange